RA Capital Management
Founded in 2004, RA Capital Management is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in early-stage companies. The firm also employs a long/short and sector-oriented hedge fund strategy. The firm prefers to invest in healthcare and life science companies developing drugs, medical devices, services & research tools, and diagnostics sectors based in the United States and European region. This firm is a Registered Investment Adviser (RIA).
Total Deals
100
Lead Investor
0
Avg Round
$117.1M
Top Stage
PIPE
Stages:
PIPE: 25
Later Stage VC (Series B): 14
Later Stage VC (Series C): 14
Early Stage VC (Series A): 12
Industries:
Drug Discovery: 61
Biotechnology: 13
Drug Delivery: 4
Discovery Tools (Healthcare): 3
Investment History
Chronological investment activity
Stage
ILiAD Biotechnologies
Later Stage VC (Series B)
Feb 2026
$115M
—
ILiAD Biotechnologies
Later Stage VC (Series B)
Drug Discovery
Feb 2026
$115M
+1 co-investors
Angitia Biopharmaceuticals
Later Stage VC (Series D)
Feb 2026
$130M
—
Angitia Biopharmaceuticals
Later Stage VC (Series D)
Drug Discovery
Feb 2026
$130M
+16 co-investors
ALX Oncology
PIPE
Jan 2026
$150M
—
ALX Oncology
PIPE
Drug Discovery
Jan 2026
$150M
+10 co-investors
Avalanche (Alternative Energy Equipment)
Later Stage VC
Jan 2026
$29.2M
—
Avalanche (Alternative Energy Equipment)
Later Stage VC
Alternative Energy Equipment
Jan 2026
$29.2M
+5 co-investors
CORXEL Pharmaceuticals
Later Stage VC (Series D1)
Jan 2026
$287M
—
CORXEL Pharmaceuticals
Later Stage VC (Series D1)
Drug Discovery
Jan 2026
$287M
+8 co-investors